118 related articles for article (PubMed ID: 15248029)
1. Synergistic killing of human leukemia cells by antioxidants and trichostatin A.
Kang J; Chen J; Zhang D; Da W; Ou Y
Cancer Chemother Pharmacol; 2004 Dec; 54(6):537-45. PubMed ID: 15248029
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Bai H; Wang C; Kang J
Pharmazie; 2006 Aug; 61(8):710-6. PubMed ID: 16964716
[TBL] [Abstract][Full Text] [Related]
3. Quercetin and trichostatin A cooperatively kill human leukemia cells.
Chen J; Kang JH
Pharmazie; 2005 Nov; 60(11):856-60. PubMed ID: 16320950
[TBL] [Abstract][Full Text] [Related]
4. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells.
Kang J; Zhang D; Chen J; Liu Q; Lin C
Toxicol In Vitro; 2005 Mar; 19(2):173-82. PubMed ID: 15649630
[TBL] [Abstract][Full Text] [Related]
5. Combination with water-soluble antioxidants increases the anticancer activity of quercetin in human leukemia cells.
Chen J; Kang J; Da W; Ou Y
Pharmazie; 2004 Nov; 59(11):859-63. PubMed ID: 15587587
[TBL] [Abstract][Full Text] [Related]
6. Histone hyperacetylation is involved in the quercetin-induced human leukemia cell death.
Jia J; Chen J
Pharmazie; 2008 May; 63(5):379-83. PubMed ID: 18557424
[TBL] [Abstract][Full Text] [Related]
7. Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells.
Chen J; Wanming D; Zhang D; Liu Q; Kang J
Pharmazie; 2005 Jan; 60(1):57-61. PubMed ID: 15700780
[TBL] [Abstract][Full Text] [Related]
8. Nickel-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Zhang Y; Chen J; Chen H; Lin C; Wang Q; Ou Y
Toxicol Sci; 2003 Aug; 74(2):279-86. PubMed ID: 12773760
[TBL] [Abstract][Full Text] [Related]
9. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A.
Lu MC; Du YC; Chuu JJ; Hwang SL; Hsieh PC; Hung CS; Chang FR; Wu YC
Arch Toxicol; 2009 Feb; 83(2):121-9. PubMed ID: 18709356
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation.
Yu C; Friday BB; Lai JP; McCollum A; Atadja P; Roberts LR; Adjei AA
Clin Cancer Res; 2007 Feb; 13(4):1140-8. PubMed ID: 17317822
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
Ishihara K; Hong J; Zee O; Ohuchi K
Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
[TBL] [Abstract][Full Text] [Related]
12. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
Chen J; Du C; Kang J; Wang J
Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cells.
Meli M; Tolomeo M; Grifantini M; Mai A; Cappellacci L; Petrelli R; Rotili D; Ferro A; Saiko P; Szekeres T; Dusonchet L
Int J Oncol; 2011 May; 38(5):1427-36. PubMed ID: 21318222
[TBL] [Abstract][Full Text] [Related]
16. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
[TBL] [Abstract][Full Text] [Related]
17. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
Wetzel M; Premkumar DR; Arnold B; Pollack IF
J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
[TBL] [Abstract][Full Text] [Related]
18. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxygen species and histone acetylation.
Chen J; Han J; Wang J
Toxicol Ind Health; 2013 May; 29(4):360-6. PubMed ID: 22294440
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells.
Roh MS; Kim CW; Park BS; Kim GC; Jeong JH; Kwon HC; Suh DJ; Cho KH; Yee SB; Yoo YH
Apoptosis; 2004 Sep; 9(5):583-9. PubMed ID: 15314286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
